Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Efklidis, Raptis"'
Autor:
Efklidis Raptis
Publikováno v:
Signa Vitae. 17:56
Chronic pain treatment is often compromised by adverse reactions, low efficacy, and potentially dangerous drug interactions. Genetics may, in some cases, help avoid such issues and it is conceivable that, in the near future, the treatment of chronic
Autor:
Athina Vadalouca, Eriphili Argyra, Ioanna Siafaka, Efklidis Raptis, Evmorfia Stavropoulou, Aikaterini Melemeni
Publikováno v:
Pain Practice. 14:32-42
Objectives Neuropathic cancer pain (NCP) is a common manifestation of cancer and/or its treatment. Treatment following the WHO analgesic ladder provides relief for the majority of cancer pain patients; however, concern remains that opioids may be les
Autor:
Ioanna Siafaka, Efklidis Raptis, Panagiota Sykioti, Panagiotis Zis, Eleni Moka, Athina Vadalouca
Publikováno v:
Pain Practice. 12:219-251
Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer-related, namely resulting from nervous system tumor invasion, surgical nerve damage during tumor removal, radiation-induced nerve damage and chemotherapy-related
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Vassilis Fragoulakis,1 Efklidis Raptis,2 Elli Vitsou,2 Nikolaos Maniadakis1 1Health Services Organization and Management, National School of Public Health, 2Pfizer Hellas, Athens, Greece Aim: The aim of the present study was to estimate the annual pe
Autor:
Athina, Vadalouca, Efklidis, Raptis, Eleni, Moka, Panagiotis, Zis, Panagiota, Sykioti, Ioanna, Siafaka
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 12(3)
Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer-related, namely resulting from nervous system tumor invasion, surgical nerve damage during tumor removal, radiation-induced nerve damage and chemotherapy-related
Autor:
A. Moutzouri, Efklidis Raptis, Ioanna Siafaka, Evmorfia Stavropoulou, Eriphylli Argyra, Athina Vadalouca
Publikováno v:
European Journal of Pain Supplements. 4:125-126